Last reviewed · How we verify
Tetrahydrobiopterin deficiency
Approved treatments
- Tetrahydrobiopterin · University of Massachusetts, Worcester
- Kuvan · BioMarin
Kuvan works by activating the enzyme Phenylalanine Hydroxylase to break down phenylalanine.
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- Tetrahydrobiopterin deficiency patent landscape — cliff calendar, originator estates, attackable patents
- Tetrahydrobiopterin deficiency treatment landscape brief
- Tetrahydrobiopterin deficiency treatment updates RSS
Frequently asked questions about Tetrahydrobiopterin deficiency
What drugs treat Tetrahydrobiopterin deficiency?
Tracked treatments include Tetrahydrobiopterin, Kuvan.
What is the treatment for Tetrahydrobiopterin deficiency?
Standard treatment for Tetrahydrobiopterin deficiency includes Tetrahydrobiopterin, Kuvan. See the treatment landscape page for first-line, second-line and salvage options.
Related
- Treatment landscape: Tetrahydrobiopterin deficiency patent cliff · Tetrahydrobiopterin deficiency CI report
- Treatment: Tetrahydrobiopterin · University of Massachusetts, Worcester
- Treatment: Kuvan · BioMarin
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing